✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Genmab A/S

Common Name
Genmab
Country
Denmark
Sector
Healthcare
Industry
Biotechnology
Employees
3,088
Ticker
GMAB
Exchange
Nasdaq Copenhagen
Description
Genmab A/S is a biotechnology company headquartered in Copenhagen, Denmark, specializing in the discovery and development of antibody-based therapeutics primarily for cancer and other serious diseases...

Genmab's Climate Target Data Preview

As of 2025, Genmab has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Genmab's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
-42%a
2030
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
-90%a
2050
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/climate-targets?ticker=GMAB"

Verified Sources Behind Genmab’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Genmab's Annual Report 2025

Insights into Genmab's Greenhouse Gas Emissions Pathways

As of 2025, Genmab has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a

Does Genmab have a target to reduce the emissions from its operations?

As of 2025, Genmab has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Genmab's most ambitious operational target is to reduce these emissions by 90% by 2050, compared to a baseline of 1,825 Metric Tonnes of CO2 equivalent (mtCO2e) in 2024.a

As of 2025, Genmab is ahead of schedule on its operational emissions reduction target, having achieved 62.47% of the planned reduction.a

Genmab's Operational (Scope 1+2) Emissions Pathway

202420252030205005001 k1.5 k2 kBaselineCurrent (-56%)Target 2030 (-42%)Target 2050 (-90%)
Want Full Access to Genmab's Climate Targets Dataset?
Start 30-Day Free Trial